T-reg cell growth and reperfusion treatment
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
150
NCT06688331
Treatment of Pre-diabetic State in Pediatric Population With Treg Cell Preparations and Rituximab
Phase: Phase 2
Role: Lead Sponsor
Start: Mar 12, 2025
Completion: Dec 31, 2032
Loading map...